SCHEMBL30394233

SCHEMBL30394233

c1ccc2oc(-c3ccc(N(c4ccc(-c5ccc(-c6cccc7ccccc67)cc5)cc4)c4ccc(-c5nc6ccccc6s5)cc4)cc3)cc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ APP P05067 5/20 0.45
▸ MAPT P10636 6/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ POLB P06746 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ CTDSP1 Q9GZU7 1/20 0.40
▸ RAB9A P51151 6/20 0.39
▸ NPC1 O15118 5/20 0.39
▸ KDM4E B2RXH2 4/20 0.39
▸ GLA P06280 2/20 0.39
▸ GAA P10253 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MMP9 P14780 1/20 0.39
▸ MMP8 P22894 1/20 0.39
▸ THRB P10828 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ GALK1 P51570 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26102665 1.00 MEN1 (0.47) MEN1KMT2ANPSR1APPMAPT
SCHEMBL26102109 1.00 MEN1 (0.47) MEN1KMT2ANPSR1APPMAPT
SCHEMBL26103395 1.00 MEN1 (0.47) MEN1KMT2ANPSR1APPMAPT
SCHEMBL25511591 0.90 APP (0.54) MEN1KMT2ANPSR1APPMAPT
SCHEMBL24229167 0.89 APP (0.51) MEN1KMT2ANPSR1APPMAPT
SCHEMBL27257533 0.86 APP (0.58) MEN1KMT2AAPPMAPTALDH1A1
SCHEMBL30395054 0.86 MEN1 (0.47) MEN1KMT2ANPSR1APPMAPT
SCHEMBL30394811 0.86 MEN1 (0.47) MEN1KMT2ANPSR1APPMAPT
SCHEMBL26134326 0.86 MEN1 (0.47) MEN1KMT2ANPSR1APPMAPT
SCHEMBL26101509 0.86 MEN1 (0.47) MEN1KMT2ANPSR1APPMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240352009-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME HODOGAYA CHEMICAL CO., LTD. (JP) 2024-10-24 — — US disclosed
EP-4424682-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME Hodogaya Chemical Co., Ltd. (JP) 2024-09-04 — — EP disclosed
CN-117980304-A Amine compound and organic electroluminescent element using same 保土谷化学工业株式会社 2024-05-03 — — CN disclosed
WO-2023074767-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME 保土谷化学工業株式会社 2023-05-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240352009-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME EZH1, AZI2, EPCAM MEN1 1970/4885KMT2A 1410/4885NPSR1 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback